The use of toluidine blue in the detection of pre-malignant and malignant oral lesions

Journal of Oral Pathology and Medicine

Volumn 40, Issue 4, 2011, Pages 300-304

  Cancela Rodríguez, Paloma ^a   Cerero Lapiedra, Rocío ^a   Esparza Gómez, Germán ^a   Llamas Martínez, Silvia ^a   Warnakulasuriya, Saman ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dysplastic lesions; Early detection; Malignant disorders; Oral cancer; Toluidine blue

Indexed keywords

TOLONIUM CHLORIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH MUCOSA; ORAL BIOPSY; PRECANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; VALIDITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COLORING AGENTS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOLONIUM CHLORIDE; YOUNG ADULT;

EID: 79952858010     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00985.x     Document Type: Article

References (37)

1. Gomez I, Warnakulasuriya S, Varela-Centelles PI, et al. Is early diagnosis of oral cancer a feasible objective? Who is to blame for diagnostic delay. Oral Dis 2010; 16: 333-42.
2. Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol 2001; 2: 239-51.
3. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weakness and scope for improvement. J Oral Pathol Med 2008; 37: 127-33.
4. Neville B, Day TA. Oral cancer and precancerous lesions. Cancer J Clin 2002; 52: 195-215.
5. Das BR, Nagpal JK. Understanding the biology of oral cancer. Med Sci Monit 2002; 8: RA258-67.
6. Wilson JMG, Junger JY. Principles and practice of mass screening for disease. Public Health Pap No 34, 1968.
7. López ML, Valle del MO, Cueto A. Knowledge of the European code against cancer in sixth - form pupils and teachers in Asturias (Spain). Eur J Cancer Prev 1994; 3: 207-13.
8. Niebel HH, Chomet B. In vivo staining test for delineation of oral intraepithelial neoplastic change: preliminary report. J Am Dent Assoc 1964; 68: 801-6.
9. Epstein JB, Sciubba J, Silverman S Jr, Sroussi HY. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck 2007; 29: 948-58.
10. World Health Organization. Guide to epidemiology and diagnosis of oral mucosal diseases and condition. Com Dent Oral Epidemiol 1980; 8: 1-26.
11. Mashberg A. Tolonium (toluidine blue) rinse: a screening method for recognition of squamous carcinoma - continuing prospective study of oral cancer IV. J Am Med Assoc 1981; 245: 2408-10.
12. Mashberg A. Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma. J Am Dent Assoc 1983; 106: 319-23.
13. Silman A. Epidemiologic studies - a practical guide. Cambridge: Cambridge University Press, 1995.
14. Shedd DP, Hukill P, Bahn S. In vivo staining properties of oral cancer. Am J Surg 1965; 110: 631-4.
15. Shedd DP, Hukill P, Bahn S, et al.. Further appraisal of in vivo staining properties of oral cancer. Arch Surg 1967; 95: 16-22.
16. Vahidy NA, Zaidi SHM, Jafarey NA. Toluidine blue test for detection of carcinoma of the oral cavity: an evaluation. J Surg Oncol 1972; 4: 434-8.
17. Reddy CRM, Ramulu C, Sundareshwar B, Raju MVS, Gopal R, Sarma R. Toluidine blue staining of oral cancer and precancerous lesions. Indian J Med Res 1973; 61: 1161-4.
18. Singurson A, Willen R. In vivo färgning med Toluidine blue som hjälpmedel för lokalisation av provexcisionsställe vid misstänkt skivepitelcancer i munhålan. Swed Dent J 1975; 68: 117-26.
19. Mashberg A. Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer. Cancer 1980; 46: 758-63 (175).
20. Silverman S Jr, Migliorati C, Barbosa J. Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Med Oral Pathol 1984; 57: 379-82 (176).
21. Lobos J, Canales M. Correlación diagnóstico histológica con test de azul de toluidina y citología exfoliativa en lesiones benignas, precancerosas y cancerosas de la mucosa oral. Av Odontoestomatol 1993; 9: 421-5.
22. ® toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 1996; 25: 97-103.
23. Epstein JB, Scully C. Assessing the patient at risk for squamous cell carcinoma. Spec Care Dentist 1997; 17: 120-8.
24. Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol 1998; 8: 444-6.
25. Onofre M, Sposto M, Navarro C. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 535-40.
26. Epstein J, Zhang L, Poh C, Nakamura H, Berean K, Rosin M. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Endod 2003; 95: 45-50.
27. Epstein J, Feldman R, Dorlor RJ, Porter S. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 2003; 25: 911-21.
28. Cheng B, Yang L. The clinical evaluation of oratest in detecting oral mucosal lesions. Hua Xi Kou Qiang Yi Xue Za Zhi 2003; 21: 124-6.
29. Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 2005; 34: 521-7.
30. Gandolfo S, Pentenero M, Braoccoleti R, Pagano M, Carrozzo M, Scully C. Toluidine blue uptake in malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol 2006; 42: 89-95.
31. Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol 1989; 67: 621-7.
32. Gray M, Gold L, Burls A, Elley K. The effectiveness of toluidine blue dye as an adjunct to oral cancer screening in general dental practice report 24. WMHTAC, Department of Public Health and Epidemiology, University of Birmingham, Birmingham. 2000. Available at: (accessed on 13 September, 2010).
33. Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc 2008; 139: 896-905.
34. Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesions biopsies indentified and evaluated by visual examination, chemiluminiscence and toluidine blue. Oral Oncol 2008; 44: 538-44.
35. Zhang L, Williams M, Poh CF, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005; 65: 8017-21.
36. Wulff HR, Gotzsche PC. Rational diagnosis and treatment: evidence based clinical decision-making, 3rd edn. Oxford: Blackwell Scientific, 2000.
37. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008; 44: 10-2.